Clinical Trial Update: Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating whole-body F-18 sodium fluoride PET/CT and whole-body MRI to detect bone metastases in prostate cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Bone Metastases, Recurrent Prostate Cancer | EARLY_Phase 1 | Status: COMPLETED